 inhibition metabolic oxalate production sulfhydryl compounds number sulfhydryl compounds oxalate formation glyoxylate rat liver homogenates hepatocytes significant inhibition cysteine inhibition concentration-dependent rats hyperoxaluric ethylene glycol drinking water daily intraperitoneal injections cysteine rapid marked decrease urinary oxalate excretion duration treatment days time period level urinary oxalate excretion ethylene glycol-treated rats controls decrease due formation cysteine-glyoxylate adduct carboxylate glyoxylate Cysteine similar sulphydryl compounds potential therapeutic agents prevention renal stones